Home

Vivo Ventures Fund V, L.P.

CIK 1398937 · last filed 2019-12-03

Vivo Ventures Fund V, L.P. is a corporate insider who has filed 9 SEC Form 4 insider transactions across 5 companies since 2013. The most recent filing shows the insider sold $165.4K of SLNO on Dec 3, 2019. Across all open-market trades the lifetime net is −$29.1M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

9

Lifetime Open-Market Net

-$29.07M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SOLENO THERAPEUTICS INC (SLNO) Delisted 10%+ Owner 242,254 $53.01 $12.84M -$249.2K 2 2019-12-03
SOLENO THERAPEUTICS INC (SLNOW) Delisted 10%+ Owner 3,886,226 — — -$40.8K 1 2019-11-07
SOLENO THERAPEUTICS INC (CAPN.W) Delisted 10%+ Owner 79,653 — — $0 3 2016-01-12
Sagent Pharmaceuticals, Inc. (SGNT) Delisted 10%+ Owner 3,496,951 — — -$28.45M 1 2015-11-04
Lite Strategy, Inc. (MEIP) Delisted 10%+ Owner 11,561 $3.20 $37.0K -$330.9K 2 2013-07-02

Recent Filings

9 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-12-03 SOLENO THERAPEUTICS INC (SLNO) Delisted Sell (S) −102,084 -$165.4K EDGAR
2019-11-27 SOLENO THERAPEUTICS INC (SLNO) Delisted Sell (S) −54,207 -$83.8K EDGAR
2019-11-07 SOLENO THERAPEUTICS INC (SLNOW) Delisted Sell (S) −26,292 -$40.8K EDGAR
2016-01-12 SOLENO THERAPEUTICS INC (CAPN.W) Delisted Other (J) +1,001,361 $0 EDGAR
2015-11-23 SOLENO THERAPEUTICS INC (CAPN.W) Delisted Other (J) +4,929,927 $0 EDGAR
2015-11-04 Sagent Pharmaceuticals, Inc. (SGNT) Delisted Sell (S) −1,809,531 -$28.45M EDGAR
2015-08-18 SOLENO THERAPEUTICS INC (CAPN.W) Delisted Other (J) +3,153,762 $0 EDGAR
2013-07-02 Lite Strategy, Inc. (MEIP) Delisted Sell (S) −1,278 -$9.7K EDGAR
2013-06-13 Lite Strategy, Inc. (MEIP) Delisted Sell (S) −41,181 -$321.2K EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.